Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.810 | 1.000 | 4 | 2014 | 2018 | |||||
Malignant tumor of colon
|
688 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.710 | 1.000 | 4 | 2011 | 2016 | |||||
Adenocarcinoma of large intestine
|
432 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
Colorectal Neoplasms
|
609 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
Malignant neoplasm of large intestine
|
375 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||
Blood Protein Measurement
|
2575 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Breast Carcinoma
|
2793 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.040 | 1.000 | 4 | 2004 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||
Atrial Fibrillation
|
584 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Carcinoma of lung
|
1204 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2012 | 2019 | |||||
Coronary heart disease
|
1178 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2012 | 2012 | |||||
Hepatitis C
|
347 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||
Malignant neoplasm of lung
|
1142 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2012 | 2019 | |||||
Myocardial Infarction
|
680 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2006 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.020 | 1.000 | 2 | 2012 | 2019 | |||||
Acquired aplastic anemia
|
12 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Adult Liver Carcinoma
|
72 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Androgen-Insensitivity Syndrome
|
176 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Aortic Aneurysm, Abdominal
|
90 | 0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 | 0.010 | 1.000 | 1 | 2015 | 2015 |